These compounds may interact with:
MAP kinase-interacting serine/threonine-protein kinase 1
Potentially involved in: carcinoma; cancer; substance-related disorders; adult high grade glioma; astrocytoma; atypical teratoid / rhabdoid tumor; ependymoma; glioblastoma; group 3 medulloblastoma; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); medulloblastoma, large-cell; non-small cell lung cancer; osteosarcoma; ovarian cancer; pancreatic cancer; pick disease; primary pancreatic ductal adenocarcinoma; primitive neuroectodermal tumor
Disease data sourced from Pharos.